ONY Biotech products

ONY Biotech is partnering with a start-up company formed by faculty in Chemical and Bioengineering at the University at Buffalo to develop acellular tissue engineered vessels (ATEV). Once implanted, the ATEV evolves over a few weeks into an anatomically and physiologically normal blood vessel populated by the recipient’s own cells. This technology may offer new options for vascular anomalies and diseases.

First breath. First steps. First day of school. Since its FDA approval in 1998, ONY Biotech has made tomorrow possible for so many premature babies and their families, thanks to Infasurf®(calfactant). ONY Biotech’s primary commercial product, Infasurf®(calfactant), helps prevent and treat respiratory distress syndrome in newborns, restoring surface activity in the lungs and quickly improving respiration.